Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Dova, Salix sign exclusive co-promotion deal for Doptelet
Dova Pharmaceuticals, Salix Pharmaceuticals and its parent company Bausch Health Companies have entered into an exclusive agreement to co-promote Dova’s Doptelet (avatrombopag) in the US.
Production & Sales - Marketing & Sales
-
28 Sep 2018
-
20 Sep 2018
Norgine to commercialize Shield’s iron deficiency therapy in Europe, Australia and New Zealand
Shield Therapeutics and Norgine have entered into an exclusive licence agreement in Europe, Australia and New Zealand, under which Norgine will commercialise Feraccru, Shield’s approved product for the treatment of iron deficiency in adults.
-
06 Jun 2017
Perrigo CEO to retire, search committee created to find replacement
Perrigo said its current CEO John Hendrickson is retiring and it has started a search for a replacement.
-
13 Feb 2017
Sanofi agrees to divest five OTC products to Ipsen for EUR83m
Sanofi has agreed to divest five of its over-the-counter consumer healthcare products in Europe to French pharma firm Ipsen for €83m.